Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court upheld his lifetime ban. 👉 Read the story here: https://reut.rs/427Hri5 Keep up with the latest news from around the world: https://www.reuters.com/ #News #Reuters #newsfeed #pharma #martinshkreli #daraprim #pharmabro #medicines #pharmaindustry Subscribe: http://smarturl.it/reuterssubscribe Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled. Get the latest news on: https://www.reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/Reuters Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en